Eliminating Diagnostic Delays in Psoriatic Arthritis

Psoriatic arthritis (PsA) is a progressive, erosive, chronic, heterogeneous, systemic inflammatory disease affecting six different clinical domains and presents in up to 30% of patients with psoriasis (PsO). Beyond issues caused with joints and skin, PsA can also lead to fatigue, poor sleep quality, diminished work capacity, physical function limitations, and decreased social participation. Early detection and treatment are critical for improving long-term patient outcomes and minimizing irreversible joint damage. Unfortunately, delays in diagnosis of PsA are common.

The first episode of this CMEOCast podcast series on PsA focuses on recognizing and reducing the impact of delays to diagnosis as well as seizing opportunities to screen patients with PsO for PsA to facilitate a prompt referral and initiation of treatment to optimize outcomes.

- Learning Objectives -

At the end of this CE activity, participants should be able to:
- Decrease diagnostic delays through better identification of signs and symptoms of PsA.

The following learning objectives pertain only to those requesting CNE or CPE credit:
- Identify signs and symptoms of PsA to decrease diagnostic delays.